Page 94 - Industrial Plant 2020
P. 94

agribusiness and food transformation.    Due to above, it reasonable to expect a remarkable
                             There are several possibilities to increase the   increase of business in Pharma market, in Germany and
                             business in strategic sectors related to the   generally worldwide.
                             industrial plants engineering.           Since 2019 M2E is involved in the industrial area of Ulm,
                                                                      inside the TEVA production complex Ulm lies in the
                             On the other  side, the German branch, as said   federal German state of Baden-Württemberg.
                             before, is essentially oriented to the pharmaceutical
                             industry: the German market is basically the major   The other important sector where M2E in involved is the
                             in Europe and the third one in all over the world   Chemicals: is the largest chemicals industry in Europe
                             just after United States and Japan.      and the fourth largest in the world. 
                             The market value is approximately 53 billion euros,   At the moment M2E is involved in PISA Projects (new
                             2019 value, and it was 38 in 2009:  4.9% annual   polyamide 12 production complex, to be built at the
                             growth.                                  Marl Chemical Park, Marl, Germany) providing staffing
                             In 2021 the overall market value should be 68   services for Construction Management phase.
                             billion euros (forecast before COVID-19).
                                                                      At last, in order to provide the recruitment and staffing
                             Therefore, taking in consideration the COVID-19   services, M2E Projects in 2019 has achieved the AÜG
                             issue, there are significant global efforts underway   license (Arbeitnehmerüberlassungsgesetz).
                             to diagnose, treat and prevent infections from the   Both of our new branches could generate several
                             virus. Pharmaceutical companies are working   opportunities such as:
                             globally to combat COVID-19.
                             Pharmaceutical companies have deep scientific   •   to develop new countries and markets;
                             knowledge gained from decades of experience   •   to acquire new clients;
                             with similar viruses. Companies are researching   •   to develop agreement with local suppliers;
                             vaccine candidates and undertaking inventories of   •   to improve local recruitment according to the EPC
                             research  portfolio  libraries  to identify  additional   contractual local content.
                             potential treatments for R&D.















































            IndustrIal Plants - May 2020
    92
   89   90   91   92   93   94   95   96   97   98   99